Artificial Intelligence Biotech China Chinese education Expansion Healthcare Hong Kong Medicine Pharmaceutical Technology University
Today marked a historic occasion with the signing of an Innovative Project Cooperation Agreement between AilsynBio and Dong-E-E-Jiao, solidifying a visionary partnership at the forefront of the health industry. The agreement, officially unveiled at a ceremony held at the Hong Kong Science Park, signifies a pioneering collaboration integrating Artificial Intelligence (AI) and traditional medicine to drive innovation in the biopharmaceutical sector through advanced technology. The event brought together esteemed figures from the industry, academia, and research fields, emphasizing the strategic importance of the partnership. Notable attendees included representatives from China Resources Pharmaceutical Group, Hong Kong Science and Technology Parks Corporation,…
News Timeline:
Track the development of this news story across the Internet.